After years of research, therapies tailored to the genomes of individual patients are reaching maturity
A still-experimental drug demonstrates the qualities of an ideal painkiller in a test in monkeys
Researchers think they’re close to a cure for the common cold, but they first need to solve a complex problem that’s perplexed scientists for decades
A new law to let dying patients access unapproved drugs raises false hope
New research suggests it is time for a categorization change
Most people diagnosed with the disease survive less than two years
Could psychedelics lead to improved antidepressant or antianxiety therapies?
We take for granted the purity of prescription and over-the-counter drugs. But they are not always safe. What stands between us and impure medicines?
The move could have benefits far beyond one medical school
A novel drug is intended to help women who suffer from depression after childbirth
People infected with the once-deadly virus can now be donors
The U.S. FDA decision comes after fits and stops for RNA-interference therapies
Clinicians were contacted about fatal overdoses
Health workers must plan vaccination effort amidst fighting in the eastern Democratic Republic of the Congo
Shutting down an overactive enzyme could become a general treatment, rather than one solely intended for the few who inherit a mutated Parkinson’s gene
NPR science journalist Richard Harris talks about his book, Rigor Mortis: How Sloppy Science Creates Worthless Cures, Crushes Hope and Wastes Billions.
The surprising insight could provide foundation for future cure
Certain proteins that coordinate the healing response are present at higher levels in oral tissue—meaning wounds in the mouth fix faster. Christopher Intagliata reports.
The genetics testing company and GlaxoSmithKline are using five million people’s data to develop medical treatments
The surprising results have buoyed hopes for treatment